{
"id":"mk19_bb_on_s9",
"subspecialtyId":"on",
"title":"Ovarian Cancer",
"jsonContent":{
"type":"section",
"id":"mk19_bb_on_s9",
"title":{
"__html":"Ovarian Cancer"
},
"titleNode":{
"type":"section-title",
"hlId":"2d1991",
"children":[
"Ovarian Cancer"
]
},
"children":[
{
"type":"section",
"id":"mk19_bb_on_s9_1",
"title":{
"__html":"Prevention"
},
"titleNode":{
"type":"section-title",
"hlId":"c53b76",
"children":[
"Prevention"
]
},
"children":[
{
"type":"p",
"hlId":"53b778",
"children":[
"Oophorectomy after childbearing or at age 35 years can be offered to women with ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"BRCA1"
]
},
"/",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"2"
]
},
" and mismatch repair genetic mutations or ≥2 first-degree relatives with ovarian cancer."
]
}
]
},
{
"type":"section",
"id":"mk19_bb_on_s9_2",
"title":{
"__html":"Screening"
},
"titleNode":{
"type":"section-title",
"hlId":"db7551",
"children":[
"Screening"
]
},
"children":[
{
"type":"p",
"hlId":"2a2a5c",
"children":[
"Screening women at average risk for ovarian cancer is not indicated. Screening women with high-risk genetic mutations has no proven benefit."
]
}
]
},
{
"type":"section",
"id":"mk19_bb_on_s9_3",
"title":{
"__html":"Diagnosis"
},
"titleNode":{
"type":"section-title",
"hlId":"523223",
"children":[
"Diagnosis"
]
},
"children":[
{
"type":"p",
"hlId":"1d1a30",
"children":[
"Patients may have a family history of breast, ovarian, or colon cancer. Characteristic findings are abdominal swelling, ascites, and pain, as well as abnormal vaginal bleeding and dyspareunia. A pelvic mass or nodularity may be present in the cul-de-sac."
]
}
]
},
{
"type":"section",
"id":"mk19_bb_on_s9_4",
"title":{
"__html":"Testing"
},
"titleNode":{
"type":"section-title",
"hlId":"fa6a5a",
"children":[
"Testing"
]
},
"children":[
{
"type":"p",
"hlId":"2c1b8d",
"children":[
"If ovarian cancer is suspected, CT or MRI of the abdomen and pelvis and chest imaging are performed to assess disease extent. ",
{
"type":"alert",
"children":[
"In patients with an adnexal mass without ascites, surgical removal of the mass without biopsy is associated with a survival benefit."
]
},
" In patients with advanced disease, diagnosis may be made by cytologic examination of ascites or pleural effusion or biopsy of peritoneal masses."
]
},
{
"type":"heading",
"class":"tricked",
"children":[
"Don't Be Tricked"
]
},
{
"type":"list",
"class":"tricked",
"children":[
" ",
{
"type":"list-item",
"hlId":"421cfe",
"children":[
"Do not obtain biopsy for early ovarian cancer."
]
},
" ",
{
"type":"list-item",
"hlId":"e83299",
"children":[
"Women with peritoneal ",
{
"type":"abbreviation",
"title":"carcinoma of unknown primary",
"children":[
"CUP"
]
},
" have ovarian cancer until proven otherwise."
]
},
" "
]
}
]
},
{
"type":"section",
"id":"mk19_bb_on_s9_5",
"title":{
"__html":"Treatment"
},
"titleNode":{
"type":"section-title",
"hlId":"4c4ac0",
"children":[
"Treatment"
]
},
"children":[
{
"type":"p",
"hlId":"09aa03",
"children":[
"Surgery is indicated to remove the ovaries and any evidence of grossly visible disease within the abdomen. Neoadjuvant therapy can be given for patients with initially unresectable disease to shrink the tumor for possible resection. Most patients with stage IA and IB disease with grade 1 (well-differentiated) histology do not receive adjuvant chemotherapy. Other patients are treated with adjuvant platinum-based chemotherapy. ",
{
"type":"alert",
"children":[
"Intraperitoneal chemotherapy shows a survival benefit in patients with small amounts of residual disease confined to the peritoneal cavity following surgery."
]
}
]
},
{
"type":"heading",
"class":"tricked",
"children":[
"Don't Be Tricked"
]
},
{
"type":"list",
"class":"tricked",
"children":[
" ",
{
"type":"list-item",
"hlId":"159569",
"children":[
"Do not opt for “second-look surgery” following completion of chemotherapy."
]
},
" ",
{
"type":"list-item",
"hlId":"1aafe1",
"children":[
"All women should undergo ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"BRCA1/2"
]
},
" testing."
]
},
" "
]
}
]
},
{
"type":"section",
"id":"mk19_bb_on_s9_6",
"title":{
"__html":"Follow-up"
},
"titleNode":{
"type":"section-title",
"hlId":"b9c20d",
"children":[
"Follow-up"
]
},
"children":[
{
"type":"p",
"hlId":"c178e0",
"children":[
"Limit follow-up to physical examination with pelvic examination and serum CA-125 measurement (if initially elevated)."
]
}
]
},
{
"type":"section",
"id":"mk19_bb_on_s9_7",
"title":{
"__html":"Test Yourself"
},
"titleNode":{
"type":"section-title",
"hlId":"7866cc",
"children":[
"Test Yourself"
]
},
"children":[
{
"type":"p",
"hlId":"35dad7",
"class":"test",
"children":[
"A 60-year-old woman has a 3-month history of increasing abdominal girth, constipation, and pain. Physical examination is normal except for ascites. Pelvic ultrasound is normal. Laparoscopy shows diffuse peritoneal carcinomatosis."
]
},
{
"type":"p",
"hlId":"9d8885",
"class":"test_answer",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Answer:"
]
},
" ",
"For diagnosis, select adenocarcinoma of unknown primary site. For management, select ovarian cancer treatment."
]
}
]
}
]
},
"tablesContent":{
}
}